leisure time -WSS

leisure time

author：hotspot 2025-10-02 00:27:51 - browse：97821

This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered every Thursday to their inbox.

I have one more, admittedly braggy thing to say about last week’s STAT Breakthrough Summit West in San Francisco. Of course we curated an incredible roster of influential industry leaders to speak on stage. That’s what STAT does. But just as remarkable were the health care and health tech A-Listers who just showed up as summit attendees to listen and learn from their peers — like 23AndMe’s Anne Wojcicki. Please join us in San Francisco next year, or better yet, register for our next summit in Boston, Oct. 16-17.

I’m back in Boston from San Francisco, but flying out again next week, this time to Chicago for the annual meeting of the American Society of Clinical Oncology. How can we be knocking on June, already?

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Novo Nordisk touts Wegovy study, but still struggling with supply

WSS

BMS, looking to build heart drug business, turns to AI for diagnosis

Illumina slashes 2023 revenue projections yet again

YouTube cracks down on misinformation on cancer treatment

Illumina slashes 2023 revenue projections yet again

How are insurers handling Leqembi and related scans?

Yogurt drink instead of a colonoscopy? CRISPR bacteria are tested

focus

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

hotspot

Peter Hotez and the public health issue of online harassment

Surge in Apellis stock fueled by confidence in safety of its eye drug

State Dept. review finds Biden bears some blame for Afghanistan failures

Sweeping indictment could be Trump's biggest legal challenge yet: ANALYSIS

Activists slam private health insurers over coverage restrictions

Rapinoe says her retirement call will help US women's soccer team to focus at World Cup

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Grail's uphill battle for Medicare to cover its cancer screening test

Apple is now the first public company to be valued at $3 trillion

Tommy Tuberville reverses his claim that white nationalists are unfairly labeled racist

hotspot

Biden administration begins canceling student loan debt for 804,000 borrowers

Senators push IRS to launch nonprofit hospital probe

Antibody drugs appear effective. Now can we make enough of them?

Megan Rapinoe shares emotional post following US Women's World Cup exit

After half a century, Israel moves to evict squatter from his cave home on the beach

Russia's threat to pull out of Ukraine grain deal raises fears about global food security

hotspot

entertainment

focus

leisure time